Octanine (Human Coagulation Factor Ix)

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It replaces deficient factor IX in patients with hemophilia B, helping to control bleeding episodes. GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanine is a recombinant factor IX product that operates within the intrinsic pathway of the clotting cascade for hemophilia B management as follows: - Hemophilia B: Provides temporary replacement of factor IX to reduce bleeding frequency and severity during bleeds or surgery . - Peri‑operative management of hemophilia B: Ensures adequate factor IX levels to maintain hemostasis during surgical procedures. - Prophylaxis of hemophilia B: Regular administration to maintain baseline factor IX levels and prevent spont sp sp sp sp sp.

Octanine may ... … … ...  … ... ... ... ... … ... ... ...

Octl ...

...